京東健康(06618.HK)續升逾7%重越20天線 中績大幅改善
京東健康(06618.HK)中期虧損大幅收窄,股價由上市低位三連彈兼先後重越10天及20天線(71.3元及75元),今早高見84元,現報78.75元,續升7.2%,成交1,089萬股(已接近昨天全日成交量)。京東健康公布,中期虧損按年大幅收窄91.5%至4.55億人民幣,每股虧損15分。期內,總收入按年增逾55%至136.38億人民幣;毛利按年升49%至33.07億元人民幣。若按非國際財務報告準則計算,京東健康中期純利更按年增80%至6.67億元人民幣。
同業阿里健康(00241.HK)由逾年半低位連升第三天,今早股價重越10天線(11.5元),最多急漲12%至12.6元,現報11.74元,續升4.2%,為最好藍籌,成交2,658萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.